Laurion Capital Management’s Genomic Health, Inc. GHDX Stock Holding History

Laurion Capital Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-21,968	Closed	-$1.54M	–	1306
2019 Q1	$1.54M	Buy	+21,968	New	+$1.63M	0.02%	440
2016 Q4	–	Sell	-94,084	Closed	-$2.72M	–	1364
2016 Q3	$2.72M	Buy	+94,084	New	+$2.62M	0.03%	418

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Laurion Capital Management's GHDX Position: Q2 2019 in Review

Laurion Capital Management sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 21,968 shares — an estimated $1.54M sold.

Laurion Capital Management first reported a position in GHDX in Q3 2016 and held it in 2 quarters. The position peaked at $2.72M in Q3 2016. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

Laurion Capital Management reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
Laurion Capital Management sold 21,968 Genomic Health, Inc. shares in Q2 2019, an estimated $1.54M.
Laurion Capital Management first reported a position in Genomic Health, Inc. in Q3 2016 and held it in 2 quarters.
Laurion Capital Management's Genomic Health, Inc. position peaked at $2.72M in Q3 2016.
215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on Laurion Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.